Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2025-12-25 @ 2:04 AM
NCT ID:
NCT00694460
Eligibility Criteria:
Inclusion Criteria:
* Male and female 12-18 months old toddlers if they
* are in good health at time of entry into the study
* are available for all the visits scheduled in the study
* have been granted a written informed consent, signed by their parents
Exclusion Criteria:
* a history of rabies immunization
* a history of Japanese encephalitis immunization or disease
* a significant acute or chronic infectious disease at the time of enrollment
* fever ≥ 38.0°C (axillary) or/and significant acute or chronic infection requiring antibiotic or antiviral therapy within the past 7 days before enrollment
* being under treatment with corticosteroids, immunosuppressive drugs or other specific anti-inflammatory drugs or having taken chloroquine during the two months period before enrollment
* administration of any vaccine within the past 14 days before enrollment
* known immunodeficiency or an autoimmune disease
* history of allergy to eggs, egg products
* known hypersensitivity to neomycin, tetracycline, amphotericin-B
* planned surgery during the study period
* being enrolled in any other investigational trial contemporaneously
* the family plans to leave the area of the study site before the end of study period
* history of febrile convulsions
* history of wheezing
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
12 Months
Maximum Age:
18 Months
Study:
NCT00694460
Study Brief:
Protocol Section:
NCT00694460